Tekla Capital Management

Tekla Capital Management LLC is a registered investment adviser based in Boston, Massachusetts, specializing in healthcare and biotechnology investments. The firm manages several closed-end equity funds, including Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ), and Tekla World Healthcare Fund (THW). These funds primarily invest in growth equities, both public and private, within the healthcare and life sciences sectors.

The firm's investment strategy focuses on identifying and investing in companies operating in various healthcare and life sciences industries, such as biotechnology, pharmaceuticals, medical devices, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology, services, devices and supplies, agriculture, and environmental management. Tekla Capital Management employs a team of professionals with diverse expertise to drive investment selection and portfolio management.

In June 2023, abrdn plc announced an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC, including four NYSE-listed healthcare and biotech thematic closed-end funds with approximately $3 billion in assets under management. This acquisition aimed to strengthen abrdn's presence in the healthcare investment sector and leverage Tekla's expertise in managing healthcare-focused funds.